Dow Down 0.62% Nasdaq Down 1.14%

Array BioPharma, Inc. (ARRY)

-NasdaqGM
3.65 Down 0.11(2.93%) Sep 22, 4:00PM EDT
|After Hours : 3.65 0.00 (0.00%) Sep 22, 4:30PM EDT
Prev Close:3.76
Open:3.73
Bid:N/A
Ask:4.49 x 500
1y Target Est:7.14
Beta:2.41
Next Earnings Date: 4-Nov-14ARRY Earnings announcement
Day's Range:3.60 - 3.77
52wk Range:3.39 - 6.66
Volume:1,455,582
Avg Vol (3m):1,471,110
Market Cap:481.15M
P/E (ttm):N/A
EPS (ttm):-0.62
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ARRY

Comparison

Symbol% ChgMkt Cap
ARRYDown 2.93%481.15M
ARQLDown 5.00%71.56M
BMYUp 0.31%85.66B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):11.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.79
Quarterly EPS Est (Sep-14) :-0.22
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):-0.48

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Array BioPharma Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule drugs to treat patients with cancer in North America, Europe, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback